Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Verdier, L; Gharbi-Benarous, J; Bertho, G; Mauvais, P; Girault, JP
   A novel mechanism of antibiotic resistance: study of the complex state of peptides with bacterial Staphylococcus aureus ribosomes
   COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE
   
   L. Verdier et al., "A novel mechanism of antibiotic resistance: study of the complex state of peptides with bacterial Staphylococcus aureus ribosomes", CR AC S IIC, 4(10), 2001, pp. 745-750
2. Dougherty, TJ; Barrett, JF
   ABT-773: a new ketolide antibiotic
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   T.J. Dougherty e J.F. Barrett, "ABT-773: a new ketolide antibiotic", EXPERT OP I, 10(2), 2001, pp. 343-351
3. Yassin, HM; Dever, LL
   Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   H.M. Yassin e L.L. Dever, "Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections", EXPERT OP I, 10(2), 2001, pp. 353-367
4. Pascual, A; Ballesta, S; Garcia, I; Perea, EJ
   Uptake and intracellular activity of ketolide HMR 3647 in human phagocyticand non-phagocytic cells
   CLINICAL MICROBIOLOGY AND INFECTION
   
   A. Pascual et al., "Uptake and intracellular activity of ketolide HMR 3647 in human phagocyticand non-phagocytic cells", CL MICRO IN, 7(2), 2001, pp. 65-69
5. Leclercq, R
   Safeguarding future antimicrobial options: strategies to minimize resistance
   CLINICAL MICROBIOLOGY AND INFECTION
   
   R. Leclercq, "Safeguarding future antimicrobial options: strategies to minimize resistance", CL MICRO IN, 7, 2001, pp. 18-23
6. Drusano, G
   Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin
   CLINICAL MICROBIOLOGY AND INFECTION
   
   G. Drusano, "Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin", CL MICRO IN, 7, 2001, pp. 24-29
7. Labro, MT; Abdelghaffar, H
   Immunomodulation by macrolide antibiotics
   JOURNAL OF CHEMOTHERAPY
   
   M.T. Labro e H. Abdelghaffar, "Immunomodulation by macrolide antibiotics", J CHEMOTHER, 13(1), 2001, pp. 3-8
8. Retsema, J; Fu, WC
   Macrolides: structures and microbial targets
   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
   
   J. Retsema e W.C. Fu, "Macrolides: structures and microbial targets", INT J ANT A, 18, 2001, pp. S3-S10
9. Dubois, J; St-Pierre, C
   In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens
   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
   
   J. Dubois e C. St-Pierre, "In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens", DIAG MICR I, 40(1-2), 2001, pp. 35-40
10. Maugein, J; Rakoto-Alson, O; Fourche, J; Launay, C; Arminaud, A; Lafargue, P; Bezian, MC; Boineau, F; Maroy, P; Cancet, B; Cassignard, D; Denjean, MP; Fabe, C; Larrouy, G; Rougier, C; Sanchez, R; Tamarelle, C; Brochet, JP; Dutilh, B; Fischer, I; Fourmau, S; Jullin, J
    In vitro activity of pristinamycine against Streptococcus pneumoniae.
    PATHOLOGIE BIOLOGIE
    
    J. Maugein et al., "In vitro activity of pristinamycine against Streptococcus pneumoniae.", PATH BIOL, 49(7), 2001, pp. 583-586
11. Bonnefoy, A; Le Priol, P
    Antibacterial activity of telithromycin (HMR 3647) in relation to in vitrosimulated human plasma kinetics
    Journal of antimicrobial chemotherapy
    
    A. Bonnefoy e P. Le Priol, "Antibacterial activity of telithromycin (HMR 3647) in relation to in vitrosimulated human plasma kinetics", J ANTIMICRO, 47(4), 2001, pp. 471-473
12. Pereyre, S; de Barbeyrac, B; Renaudin, H; Poutiers, F; Bebear, C; Bebear, CM
    In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae
    Journal of antimicrobial chemotherapy
    
    S. Pereyre et al., "In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae", J ANTIMICRO, 47(2), 2001, pp. 240-241
13. Piroth, L; Desbiolles, N; Mateo-Ponce, V; Martin, L; Lequeu, C; Charles, PE; Portier, H; Chavanet, P
    HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae
    Journal of antimicrobial chemotherapy
    
    L. Piroth et al., "HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae", J ANTIMICRO, 47(1), 2001, pp. 33-42
14. Morosini, MI; Canton, R; Loza, E; Negri, MC; Galan, JC; Almaraz, F; Baquero, F
    In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M.I. Morosini et al., "In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms", ANTIM AG CH, 45(9), 2001, pp. 2427-2431
15. Mandell, GL; Coleman, E
    Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    G.L. Mandell e E. Coleman, "Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils", ANTIM AG CH, 45(6), 2001, pp. 1794-1798
16. Neuhauser, MM; Prause, JL; Danziger, LH; Pendland, SL
    Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M.M. Neuhauser et al., "Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae", ANTIM AG CH, 45(12), 2001, pp. 3613-3615
17. Nagai, K; Davies, TA; Ednie, LM; Bryskier, A; Palavecino, E; Jacobs, MR; Appelbaum, PC
    Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S-pyogenes
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    K. Nagai et al., "Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S-pyogenes", ANTIM AG CH, 45(11), 2001, pp. 3242-3245
18. Edelstein, PH; Higa, F; Edelstein, MAC
    In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    P.H. Edelstein et al., "In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia", ANTIM AG CH, 45(10), 2001, pp. 2685-2690
19. Abdelghaffar, H; Vazifeh, D; Labro, MT
    Cellular uptake of two fluoroketolides, HMR 3562 and HMR 3787, by human polymorphonuclear neutrophils in vitro
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    H. Abdelghaffar et al., "Cellular uptake of two fluoroketolides, HMR 3562 and HMR 3787, by human polymorphonuclear neutrophils in vitro", ANTIM AG CH, 45(10), 2001, pp. 2798-2806
20. Odenholt, I; Lowdin, E; Cars, O
    Pharmacodynamics of telithromycin in vitro against respiratory tract pathogens
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    I. Odenholt et al., "Pharmacodynamics of telithromycin in vitro against respiratory tract pathogens", ANTIM AG CH, 45(1), 2001, pp. 23-29
21. Balfour, JAB; Figgitt, DP
    Telithromycin
    DRUGS
    
    J.A.B. Balfour e D.P. Figgitt, "Telithromycin", DRUGS, 61(6), 2001, pp. 815-829
22. Baltch, AL; Smith, RP; Ritz, WJ; Bopp, LH
    Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci
    CHEMOTHERAPY
    
    A.L. Baltch et al., "Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci", CHEMOTHERA, 47(4), 2001, pp. 250-260
23. Verdier, L; Gharbi-Benarous, J; Bertho, G; Evrard-Todeschi, N; Mauvais, P; Girault, JP
    Dissociation-equilibrium constant and bound conformation for weak antibiotic binding interaction with different bacterial ribosomes
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
    
    L. Verdier et al., "Dissociation-equilibrium constant and bound conformation for weak antibiotic binding interaction with different bacterial ribosomes", J CHEM S P2, (12), 2000, pp. 2363-2371
24. Kaneko, T; McArthur, H; Sutcliffe, J
    Recent developments in the area of macrolide antibiotics
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    T. Kaneko et al., "Recent developments in the area of macrolide antibiotics", EXPERT OP T, 10(4), 2000, pp. 403-425
25. Xue, YQ; Wilson, D; Sherman, DH
    Genetic architecture of the polyketide synthases for methymycin and pikromycin series macrolides
    GENE
    
    Y.Q. Xue et al., "Genetic architecture of the polyketide synthases for methymycin and pikromycin series macrolides", GENE, 245(1), 2000, pp. 203-211
26. Okamoto, H; Miyazaki, S; Tateda, K; Ishii, Y; Yamaguchi, K
    Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against Gram-positive clinical isolates in Japan
    Journal of antimicrobial chemotherapy
    
    H. Okamoto et al., "Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against Gram-positive clinical isolates in Japan", J ANTIMICRO, 46(5), 2000, pp. 797-802
27. Baltch, AL; Smith, RP; Ritz, WJ; Franke, MA; Michelsen, PB
    Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila
    Journal of antimicrobial chemotherapy
    
    A.L. Baltch et al., "Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila", J ANTIMICRO, 46(1), 2000, pp. 51-55
28. Descheemaeker, P; Chapelle, S; Lammens, C; Hauchecorne, M; Wijdooghe, M; Vandamme, P; Ieven, M; Goossens, H
    Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
    Journal of antimicrobial chemotherapy
    
    P. Descheemaeker et al., "Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates", J ANTIMICRO, 45(2), 2000, pp. 167-173
29. Mandell, GL; Coleman, EJ
    Activities of antimicrobial agents against intracellular pneumococci
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    G.L. Mandell e E.J. Coleman, "Activities of antimicrobial agents against intracellular pneumococci", ANTIM AG CH, 44(9), 2000, pp. 2561-2563
30. Davies, TA; Dewasse, BE; Appelbaum, PC
    In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    T.A. Davies et al., "In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae", ANTIM AG CH, 44(2), 2000, pp. 414-417
31. Maurin, M; Mersali, NF; Raoult, D
    Bactericidal activities of antibiotics against intracellular Francisella tularensis
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M. Maurin et al., "Bactericidal activities of antibiotics against intracellular Francisella tularensis", ANTIM AG CH, 44(12), 2000, pp. 3428-3431
32. Lee, VJ; Miller, GH; Yagisawa, M
    What's new in the antibiotic pipeline
    CURRENT OPINION IN MICROBIOLOGY
    
    V.J. Lee et al., "What's new in the antibiotic pipeline", CURR OPIN M, 2(5), 1999, pp. 475-482
33. Lingerfelt, B; Champney, WS
    Macrolide and ketolide antibiotic separation by reversed phase high performance liquid chromatography
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    B. Lingerfelt e W.S. Champney, "Macrolide and ketolide antibiotic separation by reversed phase high performance liquid chromatography", J PHARM B, 20(3), 1999, pp. 459-469
34. Champney, WS; Tober, CL
    Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells
    CURRENT MICROBIOLOGY
    
    W.S. Champney e C.L. Tober, "Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells", CURR MICROB, 38(6), 1999, pp. 342-348
35. Wootton, M; Bowker, KE; Janowska, A; Holt, HA; MacGowan, AP
    In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci
    Journal of antimicrobial chemotherapy
    
    M. Wootton et al., "In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci", J ANTIMICRO, 44(4), 1999, pp. 445-453
36. Fernandez-Roblas, R; Calvo, R; Esteban, J; Bryskier, A; Soriano, F
    The bactericidal activities of HMR 3004, HMR 3647 and erythromycin againstGram-positive bacilli and development of resistance
    Journal of antimicrobial chemotherapy
    
    R. Fernandez-Roblas et al., "The bactericidal activities of HMR 3004, HMR 3647 and erythromycin againstGram-positive bacilli and development of resistance", J ANTIMICRO, 43(2), 1999, pp. 285-289
37. Credito, KL; Ednie, LM; Jacobs, MR; Appelbaum, PC
    Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    K.L. Credito et al., "Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology", ANTIM AG CH, 43(8), 1999, pp. 2027-2031
38. Hoellman, DB; Lin, GR; Jacobs, MR; Appelbaum, PC
    Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    D.B. Hoellman et al., "Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis", ANTIM AG CH, 43(1), 1999, pp. 166-168
39. KIRST HA
    RECENT DEVELOPMENTS WITH MACROLIDE ANTIBIOTICS
    Expert opinion on therapeutic patents
    
    H.A. Kirst, "RECENT DEVELOPMENTS WITH MACROLIDE ANTIBIOTICS", Expert opinion on therapeutic patents, 8(2), 1998, pp. 111-120
40. EDLUND C; SILLERSTROM E; WAHLUND E; NORD CE
    IN-VITRO ACTIVITY OF HMR-3647 AGAINST ANAEROBIC-BACTERIA
    Journal of chemotherapy
    
    C. Edlund et al., "IN-VITRO ACTIVITY OF HMR-3647 AGAINST ANAEROBIC-BACTERIA", Journal of chemotherapy, 10(4), 1998, pp. 280-284
41. Soriano, F; Fernandez-Roblas, R; Calvo, R; Garcia-Calvo, G; Pardeiro, M; Bryskier, A
    In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens
    Journal of antimicrobial chemotherapy
    
    F. Soriano et al., "In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens", J ANTIMICRO, 42(5), 1998, pp. 647-649
42. PANKUCH GA; HOELLMAN DB; LIN GR; BAJAKSOUZIAN S; JACOBS MR; APPELBAUM PC
    ACTIVITY OF HMR-3647 COMPARED TO THOSE OF 5 AGENTS AGAINST HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS BY MIC DETERMINATION AND TIME-KILL ASSAY
    Antimicrobial agents and chemotherapy
    
    G.A. Pankuch et al., "ACTIVITY OF HMR-3647 COMPARED TO THOSE OF 5 AGENTS AGAINST HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS BY MIC DETERMINATION AND TIME-KILL ASSAY", Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 3032-3034
43. Duong, M; Simard, M; Bergeron, Y; Ouellet, N; Cote-Richer, M; Bergeron, MG
    Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M. Duong et al., "Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice", ANTIM AG CH, 42(12), 1998, pp. 3309-3312
44. XUE YQ; ZHAO LS; LIU HW; SHERMAN DH
    A GENE-CLUSTER FOR MACROLIDE ANTIBIOTIC BIOSYNTHESIS IN STREPTOMYCES-VENEZUELAE - ARCHITECTURE OF METABOLIC DIVERSITY
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    Y.Q. Xue et al., "A GENE-CLUSTER FOR MACROLIDE ANTIBIOTIC BIOSYNTHESIS IN STREPTOMYCES-VENEZUELAE - ARCHITECTURE OF METABOLIC DIVERSITY", Proceedings of the National Academy of Sciences of the United Statesof America, 95(21), 1998, pp. 12111-12116
45. GARRE M; GARO B; HUTIN P
    ANTIBACTERIAL AGENTS
    Medecine et maladies infectieuses
    
    M. Garre et al., "ANTIBACTERIAL AGENTS", Medecine et maladies infectieuses, 26(1), 1996, pp. 22-25